Eric

I'm going to make a counterargument. You guys aren't going to like it. Many of these peptides, these are off-label uses of peptides because they saw different results from studies that weren't even addressing this in the exact same one the GLP-1s, which you love. It was not designed for what we're using it for, but we started noticing something.

Tessamorelin. This was developed for HIV patients. What did they find when people were on this? They had a reduction of abdominal fat. That was just a side effect they found. Very well studied, administered. It's been used for 40 years. It's a very well-known peptide, and it had this auxiliary effect of reducing abdominal fat.

Tessamorelin. This was developed for HIV patients. What did they find when people were on this? They had a reduction of abdominal fat. That was just a side effect they found. Very well studied, administered. It's been used for 40 years. It's a very well-known peptide, and it had this auxiliary effect of reducing abdominal fat.

Tessamorelin. This was developed for HIV patients. What did they find when people were on this? They had a reduction of abdominal fat. That was just a side effect they found. Very well studied, administered. It's been used for 40 years. It's a very well-known peptide, and it had this auxiliary effect of reducing abdominal fat.

Yeah. Then we could get into how many studies there are that abdominal fat is a huge indicator of future for horseman stuff. This is the Dr. Isaacson. This is a dementia.

Yeah. Then we could get into how many studies there are that abdominal fat is a huge indicator of future for horseman stuff. This is the Dr. Isaacson. This is a dementia.

Yeah. Then we could get into how many studies there are that abdominal fat is a huge indicator of future for horseman stuff. This is the Dr. Isaacson. This is a dementia.

We'd have to go through each and every one of them, but most of them weren't developed for the thing that it's being used for.

We'd have to go through each and every one of them, but most of them weren't developed for the thing that it's being used for.

We'd have to go through each and every one of them, but most of them weren't developed for the thing that it's being used for.

Latisse, this eyelash thing, was a glaucoma medicine that they found, oh, everyone using it has beautiful eyelashes.

Latisse, this eyelash thing, was a glaucoma medicine that they found, oh, everyone using it has beautiful eyelashes.

Latisse, this eyelash thing, was a glaucoma medicine that they found, oh, everyone using it has beautiful eyelashes.

What you're upset about is that there isn't the data for the off-label use. But there is plenty of data for the peptide itself in the other application. In the same way that the GLP-1 had a ton of data for diabetics before, as you said earlier, they were refusing to study it for obesity.

What you're upset about is that there isn't the data for the off-label use. But there is plenty of data for the peptide itself in the other application. In the same way that the GLP-1 had a ton of data for diabetics before, as you said earlier, they were refusing to study it for obesity.

What you're upset about is that there isn't the data for the off-label use. But there is plenty of data for the peptide itself in the other application. In the same way that the GLP-1 had a ton of data for diabetics before, as you said earlier, they were refusing to study it for obesity.

But you're at a stage where you're going, we should try it for obesity. And you're going, there's no study for obesity. It's for diabetics. And it's like, now we're post that. It turns out, no, that was great for me.

But you're at a stage where you're going, we should try it for obesity. And you're going, there's no study for obesity. It's for diabetics. And it's like, now we're post that. It turns out, no, that was great for me.

But you're at a stage where you're going, we should try it for obesity. And you're going, there's no study for obesity. It's for diabetics. And it's like, now we're post that. It turns out, no, that was great for me.

Well, because I've slept like shit forever. So that's my hunch there.